No parent ever wants to hear the words “childhood cancer.”
If you do, you want to know your child is in the best hands, receiving treatment from experts with access to the latest advancements in medicine.
WMCHealth’s Maria Fareri Children’s Hospital has those experts. Our pediatric hematologists and oncologists diagnose and treat babies, children, and teens with cancers including leukemia, lymphoma, brain tumors, and blood disorders with innovative and compassionate care. Our thriving patients are a testament to our successful and groundbreaking treatments.
Why Choose Maria Fareri Children's Hospital?
The landscape for childhood cancers at Maria Fareri Children’s Hospital involves continuous advancements. Each day brings new expertise and breakthroughs in cancer and blood diseases, with innovations like bone marrow transplantation and gene therapy enhancing treatment. Our oncologists and neurosurgeons, experienced in childhood cancers and central nervous system tumors, collaborate globally through the Children’s Brain Tumor Network to develop new treatments and contribute to pediatric brain tumor research.
Our Approach
WMCHealth’s Maria Fareri Children’s Hospital combines internationally recognized research with high-quality care, focusing on personalized and gentle treatment for cancer and blood diseases. Each child receives a tailored blend of science-based medicine and holistic support, aiming for healing of body, mind, and spirit. Family involvement and a comforting environment contribute to comprehensive care, supporting patients through physical and emotional challenges with home-like accommodations.
Pediatric Hematology/Oncology Treatments and Programs
- Cellular therapy and stem cell treatment
- Hematologic malignancy leukemia/lymphoma
- Histiocytic disorders
- Neuro-oncology
- Primary Immunodeficiencies: The Immunodeficiency Program at Maria Fareri Children’s Hospital includes several highly recognized programs in Newborn Screening, Prevention, Genetic Diagnosis, Stem Cell Transplantation, Reduced Intensity Conditioning, and Adoptive Cellular Immunotherapy. We are one of 43 centers in North America participating in the National Institutes of Health-funded Primary Immunodeficiency Treatment Consortium.
- Sickle cell disease: The Sickle Cell Disease (SCD) program is led by an experienced team of physicians, nurses, and social workers in both English and Spanish. Patients are identified through the Newborn Screening Program, and parents are contacted to arrange an appointment. By working with the Stem Cell Transplantation team, your child will get the most cutting-edge therapies available. Additionally, we are the founding center of the Haplo SCD Consortium stem cell transplant clinical trial.
- Solid tumors
- Thrombosis and hemostasis: Our team includes multiple specialists with a unique interest in hemophilia and coagulation factor problems.
Clinical Trials
The doctors and researchers of Maria Fareri Children’s Hospital are pioneers of science with over 200 studies reviewed annually. The goal of clinical trials is to find better ways to detect, prevent or treat diseases. Clinical trials test newly developed drugs, medical devices, surgical techniques, therapies, screenings, and diagnostics. Pediatric clinical trials are used to improve the quality of life for children worldwide.
Research at Work
The Childhood and Adolescent Cancer and Blood Diseases Center at Maria Fareri Children’s Hospital is an internationally-recognized, multidisciplinary diagnostic treatment and research center leading breakthrough research in cancer and blood diseases. Children and adults travel from around the country to receive the advanced cellular therapies developed at WMCHealth.